Synvista Therapeutics - Dividend History | SYNI
Historical dividend payout and yield for Synvista Therapeutics (SYNI) since 1971. The current TTM dividend payout for Synvista Therapeutics (SYNI) as of December 31, 1969 is $0.00. The current dividend yield for Synvista Therapeutics as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
|
Synvista Therapeutics, Inc. (formerly Alteon, Inc.), a product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease. The company's products include ALT-2074, a glutathione peroxidase mimetic in Phase II clinical trials for the treatment of diabetic patients with Hp2-2; and Alagebrium chloride or alagebrium, an Advanced Glycation End-product Crosslink Breaker in Phase II clinical trials for the treatment of diastolic heart failure and diabetic nephropathy. It is also developing a diagnostic test to identify and treat patients with diabetes who are in risk of cardiovascular disease.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
